Evommune, Inc. Revenue 2024–2025
Evommune, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Evommune, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Evommune, Inc. annual revenue for 2025 was 13.0 M, a 85.71% increase from 2024.
- Evommune, Inc. annual revenue for 2024 was 7.0 M.
Evommune, Inc. (EVMN) — Frequently Asked Questions
Evommune, Inc. (EVMN) is a publicly traded US company. It has a market capitalization of $126M. In fiscal 2025 it reported revenue of $13M and net income of -$69M. Explore EVMN's stock price, financial statements, earnings history, margins and key ratios below.
What is Evommune, Inc.'s market cap?
Evommune, Inc. (EVMN) has a market capitalization of $126M.
What is the EVMN stock price?
EVMN trades at $20.49.
How much revenue does Evommune, Inc. make?
Evommune, Inc. reported revenue of $13M in fiscal 2025.
Is EVMN profitable?
In fiscal 2025, Evommune, Inc. reported net income of -$69M.